Rating History for Xilio Therapeutics Inc (XLO) by Chardan

More Stocks Rated by Chardan | Latest Ratings for XLO
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/21/2022 Matthew Barcus New Coverage Buy
(N/A)		 7.00
(N/A)		 1.97
(0.53)		 -73.1% Details